Article Versions Notes

Navarro JA, Decara J, Medina-Vera D, Tovar R, Lopez-Gambero AJ, Suarez J, Pavón FJ, Serrano A, de Ceglia M, Sanjuan C, et al. Endocrine and Metabolic Impact of Oral Ingestion of a Carob-Pod-Derived Natural-Syrup-Containing D-Pinitol: Potential Use as a Novel Sweetener in Diabetes. Pharmaceutics. 2022; 14(8):1594. https://doi.org/10.3390/pharmaceutics14081594

Navarro, Juan A., Juan Decara, Dina Medina-Vera, Ruben Tovar, Antonio J. Lopez-Gambero, Juan Suarez, Francisco Javier Pavón, Antonia Serrano, Marialuisa de Ceglia, Carlos Sanjuan, and et al. 2022. "Endocrine and Metabolic Impact of Oral Ingestion of a Carob-Pod-Derived Natural-Syrup-Containing D-Pinitol: Potential Use as a Novel Sweetener in Diabetes" Pharmaceutics 14, no. 8: 1594. https://doi.org/10.3390/pharmaceutics14081594

Navarro, J. A., Decara, J., Medina-Vera, D., Tovar, R., Lopez-Gambero, A. J., Suarez, J., Pavón, F. J., Serrano, A., de Ceglia, M., Sanjuan, C., Baltasar, Y. A., Baixeras, E., & Rodríguez de Fonseca, F. (2022). Endocrine and Metabolic Impact of Oral Ingestion of a Carob-Pod-Derived Natural-Syrup-Containing D-Pinitol: Potential Use as a Novel Sweetener in Diabetes. Pharmaceutics, 14(8), 1594. https://doi.org/10.3390/pharmaceutics14081594